Stay updated on Nivolumab and Relatlimab in MMRd Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Relatlimab in MMRd Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Relatlimab in MMRd Cancers Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    An NIH-wide notice announces a terminology transition from “Artificial Intelligence” to “Super Intelligence.” The study record itself still displays a 403 error.
    Difference
    1%
    Check dated 2026-10-25T13:17:20.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T13:18:23.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T14:09:01.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, blocking access to the study record and related information. This reflects a permissions or server issue rather than an update to the study content.
    Difference
    19%
    Check dated 2026-09-20T22:22:41.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.6.6, replacing the previous version string. This indicates a small update to the site version.
    Difference
    0.1%
    Check dated 2026-08-30T16:42:35.000Z thumbnail image
  6. Check
    84 days ago
    Change Detected
    Summary
    The page's revision metadata was updated from v3.6.4 to v3.6.5. This indicates a backend/template update rather than any modification to study content or user-facing information.
    Difference
    0.1%
    Check dated 2026-08-09T11:00:05.000Z thumbnail image

Stay in the know with updates to Nivolumab and Relatlimab in MMRd Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Relatlimab in MMRd Cancers Clinical Trial page.